Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasm Metastasis × Imiquimod × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioma 4 Melanoma 3 Glioblastoma 3 Uterine Cervical Dysplasia 2 Keratosis, Actinic 2 Ependymoma 2 Breast Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sialorrhea 1 Sarcoma 1 Precancerous Conditions 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Medulloblastoma 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1 Bone Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 48 Specimen Handling 31 Biopsy 30 Magnetic Resonance Spectroscopy 29 Gemcitabine 29 Nivolumab 27 Paclitaxel 25 Bevacizumab 21 Irinotecan 20 Cyclophosphamide 20 Docetaxel 18 Cisplatin 18 Fluorouracil 17 Carboplatin 17 Cetuximab 16 Oxaliplatin 14 Leucovorin 14 Ipilimumab 13 Everolimus 13 130-nm albumin-bound paclitaxel 13 Capecitabine 12 Albumin-Bound Paclitaxel 12 Trastuzumab 11 Sorafenib 11 Radiosurgery 10 Erlotinib Hydrochloride 10 trastuzumab deruxtecan 9 spartalizumab 9 olaparib 9 Sirolimus 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡